Tonix Pharmaceuticals Holding Corp (TNXP)
NASDAQ · Healthcare
Tonix Pharmaceuticals Holding Corp EPS 2023–2025
Tonix Pharmaceuticals Holding Corp annual/quarterly eps history and growth rate from 2023 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Tonix Pharmaceuticals Holding Corp eps for the quarter ending March 31, 2026 was $2.93, a 3.17% increase year-over-year.
- Tonix Pharmaceuticals Holding Corp annual eps for 2025 was $14.57, a 91.75% decrease from 2024.
- Tonix Pharmaceuticals Holding Corp annual eps for 2024 was $176.60, a 98.80% decrease from 2023.
- Tonix Pharmaceuticals Holding Corp annual eps for 2023 was $14720.25.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Tonix Pharmaceuticals Holding Corp EPS — FAQ
Tonix Pharmaceuticals Holding Corp (TNXP) eps over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Tonix Pharmaceuticals Holding Corp's eps?
Tonix Pharmaceuticals Holding Corp (TNXP) reported eps of $-14.57 for fiscal 2025.
Where can I see TNXP's eps history?
The chart and table above show Tonix Pharmaceuticals Holding Corp's eps by year and by quarter, including the growth rate.